Potassium chloride
Highest phase reached
Approved
Drug type
Small molecule
First approval year
1982
- First approval year
- 1982
- Listing at source
- Listed
- Highest phase reached
- Approved
- Drug type
- Small molecule
- Drug name
- Potassium chloride
- Molecular weight
- 74.55
- Structure (SMILES)
These details could not be displayed.
- diffu k
- Diffu-k
- duro k
- Duro-k
- k 10
- k 8
- k contin
- k dur 20
- k lease
- k tab
- K-contin
- K-dur 20
- K-lease
- K-tab
- K+10
- K+8
- kaleorid
- Kaleorid
- kaleorid lp
- Kaleorid lp
- kaon cl
- Kaon cl
- kaon cl 10
- Kaon cl-10
- kay cee l
And 72 more, listed on the interactive page.
- b1653
- B1653
- B1653 [LANGUAL]
- b1653 langual
- Chloride (as potassium)
- CHLORIDE (AS POTASSIUM) [VANDF]
- chloride as potassium
- chloride as potassium vandf
- e 508
- E 508
- E-508
- e508
- E508
- halflytely component potassium chloride
- HALFLYTELY COMPONENT POTASSIUM CHLORIDE
- ins 508
- ins no 508
- INS NO.508
- INS-508
- kali muriaticum
- Kali muriaticum
- KALI MURIATICUM [HPUS]
- kali muriaticum hpus
- kalii chloridum
- Kalii chloridum
And 51 more, listed on the interactive page.
- CAS registry numbers
- 7447-40-7
- ChEMBL ID
- CHEMBL1200731
- InChIKey
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M
- PubChem compound IDs
- 4873
- RxNorm IDs (RxCUI)
- 8591
- FDA ingredient codes (UNII)
- 660YQ98I10
- A12BA01
- A12BA51
- B05XA01
Sources for recorded values
- Applicant
- BAXTER HLTHCARE
- Approval date
- 22 Mar 1971
- Application number
- NDA016682
- Patents
- 1
- Designations
- 0
- Earliest recorded loss of exclusivity
- 7 Mar 2039
- First in class
- No
- Fast track
- No
- Breakthrough designation
- No
- Orphan designation
- No
- Priority review
- No
- Orphan exclusivity
- No
- Accelerated approval
- No
- Availability
- Prescription only
Administration routes
- Oral
- Parenteral
- Condition
- Acid-Base Imbalance
- Highest recorded phase
- 4
- Subject identifier
- D000137
- Condition
- Fluid Therapy
- Highest recorded phase
- 4
- Subject identifier
- D005440
- Condition
- Aortic Valve Stenosis
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000266
- Subject identifier
- D001024
- Condition
- Heart Failure
- Highest recorded phase
- 3
- Condition identifier
- EFO:0000373
- Subject identifier
- D006333
- Condition
- Hypertension
- Highest recorded phase
- 3
- Condition identifier
- EFO:0000537
- Subject identifier
- D006973
- Condition
- Myocardial Infarction
- Highest recorded phase
- 3
- Condition identifier
- EFO:0000612
- Subject identifier
- D009203
- Condition
- Coronary Disease
- Highest recorded phase
- 3
- Condition identifier
- EFO:0001645
- Subject identifier
- D003327
- Condition
- Heart Failure
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003144
- Subject identifier
- D006333
- Condition
- Heart Diseases
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003777
- Subject identifier
- D006331
- Condition
- Brain Neoplasms
- Highest recorded phase
- 2
- Condition identifier
- EFO:0003833
- Subject identifier
- D001932
- Condition
- Arrhythmias, Cardiac
- Highest recorded phase
- 4
- Condition identifier
- EFO:0004269
- Subject identifier
- D001145
- Condition
- Shock, Septic
- Highest recorded phase
- 1
- Condition identifier
- EFO:0006834
- Subject identifier
- D012772
- Condition
- Heart Arrest
- Highest recorded phase
- 2
- Condition identifier
- EFO:0009492
- Subject identifier
- D006323
- Condition
- Heart Failure, Diastolic
- Highest recorded phase
- 2
- Condition identifier
- EFO:1000899
- Subject identifier
- D054144
- Condition
- Angina, Unstable
- Highest recorded phase
- 3
- Condition identifier
- EFO:1000985
- Subject identifier
- D000789
- Condition
- Constipation
- Highest recorded phase
- 3
- Condition identifier
- HP:0002019
- Subject identifier
- D003248
- Condition
- Hemorrhage
- Highest recorded phase
- 4
- Condition identifier
- MP:0001914
- Subject identifier
- D006470
- Condition identifier
- EFO_0000266
- Highest recorded phase
- 2
- Condition identifier
- EFO_0000537
- Highest recorded phase
- 2
- Condition identifier
- EFO_0003144
- Highest recorded phase
- 2
- Condition identifier
- EFO_0003833
- Highest recorded phase
- 2
- Condition identifier
- EFO_0004269
- Condition identifier
- EFO_0004269
- Highest recorded phase
- 4
- Condition identifier
- EFO_0006834
- Highest recorded phase
- 1
- Condition identifier
- EFO_0009321
- Highest recorded phase
- 1
- Condition identifier
- EFO_0009492
- Highest recorded phase
- 2
- Condition identifier
- EFO_1000899
- Highest recorded phase
- 2
- Condition identifier
- HP_0002019
- Condition identifier
- HP_0002019
- Highest recorded phase
- 4
- Condition identifier
- HP_0002900
- Condition identifier
- HP_0002900
- Highest recorded phase
- 4
- Condition identifier
- MONDO_0000190
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0005044
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0005252
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0005265
- Condition identifier
- MONDO_0005575
- Condition identifier
- MP_0001914
- Condition identifier
- MP_0001914
- Highest recorded phase
- 4
- Condition identifier
- OBA_VT0000183
- Event
- acute kidney injury
- Reports
- 124
- Reporting signal score
- 51.88
- Event
- anterior chamber cell
- Reports
- 64
- Reporting signal score
- 279.179
- Event
- anterior chamber disorder
- Reports
- 19
- Reporting signal score
- 80.792
- Event
- anterior chamber fibrin
- Reports
- 44
- Reporting signal score
- 240.277
- Event
- anterior chamber flare
- Reports
- 17
- Reporting signal score
- 70.4031
- Event
- aqueous fibrin
- Reports
- 15
- Reporting signal score
- 89.8496
- Event
- blood potassium increased
- Reports
- 55
- Reporting signal score
- 93.6021
- Event
- calcium deficiency
- Reports
- 16
- Reporting signal score
- 51.0692
- Event
- cardiac arrest
- Reports
- 55
- Reporting signal score
- 50.7456
- Event
- cataract operation complication
- Reports
- 18
- Reporting signal score
- 69.8881
- Event
- coma
- Reports
- 192
- Reporting signal score
- 340.405
- Event
- corneal oedema
- Reports
- 71
- Reporting signal score
- 238.835
- Event
- electrocardiogram t wave peaked
- Reports
- 15
- Reporting signal score
- 52.2979
- Event
- endophthalmitis
- Reports
- 179
- Reporting signal score
- 619.675
- Event
- eye inflammation
- Reports
- 73
- Reporting signal score
- 203.04
- Event
- eye pain
- Reports
- 58
- Reporting signal score
- 68.745
- Event
- foetal disorder
- Reports
- 17
- Reporting signal score
- 51.7463
- Event
- foreign body in eye
- Reports
- 22
- Reporting signal score
- 85.2772
- Event
- gastrooesophageal reflux disease
- Reports
- 180
- Reporting signal score
- 286.703
- Event
- hyperkalaemia
- Reports
- 390
- Reporting signal score
- 986.649
- Event
- hypokalaemia
- Reports
- 88
- Reporting signal score
- 80.6557
- Event
- hypopyon
- Reports
- 71
- Reporting signal score
- 301.684
- Event
- low birth weight baby
- Reports
- 34
- Reporting signal score
- 53.1858
- Event
- macular degeneration
- Reports
- 30
- Reporting signal score
- 54.939
- Event
- pneumonia aspiration
- Reports
- 168
- Reporting signal score
- 413.754
And 6 more, listed on the interactive page.
- NCT00091507
- NCT00241839
- NCT01074918
- NCT01682837
- NCT02450773
- NCT00796354
- NCT00823108
- NCT02256345
- NCT02707549
- NCT02840799
- NCT04913805
- NCT05138575
- NCT03483051
- NCT04316611
- Dose
- 4 liters
- Route
- Oral
- How often
- Every 10 minutes until 4 liters are consumed
- Consume with water
- Do not add ingredients or flavors
- Keep refrigerated 2° to 8°C
- Use within 48 hours
- Prodrug
- No
- Chirality
- Achiral
- Inorganic
- Yes
- Heavy atoms
- 2
- Molecular formula
- ClK
- Monoisotopic mass
- 73.9325592
- Natural product
- No
- 0065-0795
- 0065-1795
- 0121-0948
- 0121-1896
- 0121-2847
- 0121-4948
- 0245-0360
- 0245-0835
- 0245-0836
- 0245-5315
- 0245-5316
- 0245-5317
- 0245-5318
- 0245-5319
- 0264-1944
- 0264-1945
- 0264-2202
- 0264-2203
- 0264-2205
- 0264-7389
- 0264-7625
- 0264-7634
- 0264-7635
- 0264-7636
- 0264-7638
And 393 more, listed on the interactive page.
- Recorded assays
- 100
- Active assays
- 5
Active assay types
- Other
Related records
Trials (72)
- A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet
- A Phase II Clinical Study of QR12000 Compound Tablets in Patients With Moderate to Severe Essential Hypertension
- A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo
- A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008)
- Anti-calculus Efficacy of a Dentrifice Containing Sodium Pyrophosphate and Potassium Pyrophosphate in Heavy Calculus Formers
- Autologous Cord Blood Cells for Prevention of BPD in Preterm
- Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern
- Bilateral Dual Transversus Abdominis Plane Block for Robotic Assisted Laparoscopic Surgery
- Blockade of Vascular Potassium Channels During Human Endotoxemia
- Blood Pressure Regulation - Role of Potassium
- Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia
- Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered Evaluation
- Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).
- Clinical Evaluation of Different Potassium Oxalate Concentrations in Dentin Hypersensitivity Treatment
- Comparative Study Between Nicorandil and Nifedipine for the Treatment of Preterm Labour
- Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment
- Comparison of Enteral Versus Intravenous Potassium Supplementation
- Comparison of Two Potassium Targets Within the Normal Range in Intensive Care Patients
- Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
- Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)
Approved for (1)
- Cardiac rhythm disease
In development for (14)
- Aortic valve stenosis Phase 2
- Brain neoplasm Phase 2
- Cardiac arrest Phase 2
- Congestive heart failure Phase 3
- Constipation disorder Phase 3
- Coronary artery disorder Phase 3
- Diabetic macular edema Phase 1
- Diastolic heart failure Phase 2
- Heart disorder Phase 3
- Heart failure Phase 3
- Hypertensive disorder Phase 3
- Intermediate coronary syndrome Phase 3
- Myocardial infarction Phase 3
- Toxic shock syndrome Phase 1
Other linked conditions (1)
- Potassium deficiency disease